StockData
STAAR Surgical Co logo

STAAR Surgical Co (STAA) stock

STAANasdaqOphthalmic GoodsFiscal year ends January 2
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3067% above fair value
$25.56−0.45 (-1.73%)

Close on Nov 17, 2026Market cap $1.28BP/E 365.1Yield –

STAAR Surgical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

STAAR Surgical's pe ratio was 381.3× on Nov 11, 2026, against 134.0× a year earlier. Over the last 5 years it ranged from 55.0× to 878.4×, with a median of 134.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026381.3×+326.3
2025Jan 31, 202555.0×−0.2
2024Dec 31, 202455.2×−20.9
2023Dec 29, 202376.1×+12.3
2022Dec 30, 202263.9×−134.6
2021Dec 31, 2021198.5×−218.5
2020Dec 31, 2020416.9×+221.6
2019Dec 31, 2019195.4×−203.5
2018Dec 31, 2018398.9×+227.5
2012Jul 31, 2012171.3×−517.8
2011Dec 30, 2011689.1×–

More STAAR Surgical figures

See a number that looks wrong?